Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Status:
Completed
Trial end date:
2021-02-20
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of ferric citrate capsules for the treatment of
hyperphosphatemia in patients with chronic kidney disease undergoing hemodialysis